Global Small Molecule Targeted Cancer Therapy Market Insights and Forecast to 2028
Table of Contents1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Small Molecules
1.2.4 Small Molecule Drug Conjugates
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lymphoma
1.3.3 Melanoma
1.3.4 Multiple Myeloma
1.3.5 Breast Cancer
1.3.6 Prostate Cancer
1.3.7 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Cancer Therapy Market Perspective (2017-2028)
2.2 Small Molecule Targeted Cancer Therapy Growth Trends by Region
2.2.1 Small Molecule Targeted Cancer Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Small Molecule Targeted Cancer Therapy Historic Market Size by Region (2017-2022)
2.2.3 Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2023-2028)
2.3 Small Molecule Targeted Cancer Therapy Market Dynamics
2.3.1 Small Molecule Targeted Cancer Therapy Industry Trends
2.3.2 Small Molecule Targeted Cancer Therapy Market Drivers
2.3.3 Small Molecule Targeted Cancer Therapy Market Challenges
2.3.4 Small Molecule Targeted Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue
3.1.1 Global Top Small Molecule Targeted Cancer Therapy Players by Revenue (2017-2022)
3.1.2 Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Small Molecule Targeted Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Small Molecule Targeted Cancer Therapy Revenue
3.4 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Cancer Therapy Revenue in 2021
3.5 Small Molecule Targeted Cancer Therapy Key Players Head office and Area Served
3.6 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
3.7 Date of Enter into Small Molecule Targeted Cancer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Cancer Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2017-2022)
4.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2023-2028)
5 Small Molecule Targeted Cancer Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2017-2022)
5.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
6.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type
6.2.1 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
6.2.2 North America Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
6.2.3 North America Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
6.3 North America Small Molecule Targeted Cancer Therapy Market Size by Application
6.3.1 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
6.3.2 North America Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
6.3.3 North America Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
6.4 North America Small Molecule Targeted Cancer Therapy Market Size by Country
6.4.1 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022)
6.4.2 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
7.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type
7.2.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
7.2.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
7.2.3 Europe Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
7.3 Europe Small Molecule Targeted Cancer Therapy Market Size by Application
7.3.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
7.3.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
7.3.3 Europe Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
7.4 Europe Small Molecule Targeted Cancer Therapy Market Size by Country
7.4.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022)
7.4.2 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
8.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type
8.2.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application
8.3.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region
8.4.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
9.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type
9.2.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
9.3 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application
9.3.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
9.4 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country
9.4.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size (2017-2028)
10.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type
10.2.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application
10.3.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country
10.4.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 OncoGenex Pharmaceuticals, Inc.
11.1.1 OncoGenex Pharmaceuticals, Inc. Company Details
11.1.2 OncoGenex Pharmaceuticals, Inc. Business Overview
11.1.3 OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Introduction
11.1.4 OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.1.5 OncoGenex Pharmaceuticals, Inc. Recent Developments
11.2 Cytokinetics Inc.
11.2.1 Cytokinetics Inc. Company Details
11.2.2 Cytokinetics Inc. Business Overview
11.2.3 Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Introduction
11.2.4 Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.2.5 Cytokinetics Inc. Recent Developments
11.3 Hospira Inc.
11.3.1 Hospira Inc. Company Details
11.3.2 Hospira Inc. Business Overview
11.3.3 Hospira Inc. Small Molecule Targeted Cancer Therapy Introduction
11.3.4 Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.3.5 Hospira Inc. Recent Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.4.5 GlaxoSmithKline plc Recent Developments
11.5 Boehringer Ingelheim GmbH
11.5.1 Boehringer Ingelheim GmbH Company Details
11.5.2 Boehringer Ingelheim GmbH Business Overview
11.5.3 Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Introduction
11.5.4 Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.5.5 Boehringer Ingelheim GmbH Recent Developments
11.6 Bayer HealthCare AG
11.6.1 Bayer HealthCare AG Company Details
11.6.2 Bayer HealthCare AG Business Overview
11.6.3 Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Introduction
11.6.4 Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.6.5 Bayer HealthCare AG Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Details
11.7.2 Abbott Laboratories Business Overview
11.7.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Introduction
11.7.4 Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022)
11.7.5 Abbott Laboratories Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of TablesTable 1. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Small Molecules
Table 4. Key Players of Small Molecule Drug Conjugates
Table 5. Global Small Molecule Targeted Cancer Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Small Molecule Targeted Cancer Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Small Molecule Targeted Cancer Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2017-2022)
Table 9. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Small Molecule Targeted Cancer Therapy Market Share by Region (2023-2028)
Table 11. Small Molecule Targeted Cancer Therapy Market Trends
Table 12. Small Molecule Targeted Cancer Therapy Market Drivers
Table 13. Small Molecule Targeted Cancer Therapy Market Challenges
Table 14. Small Molecule Targeted Cancer Therapy Market Restraints
Table 15. Global Small Molecule Targeted Cancer Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Small Molecule Targeted Cancer Therapy Revenue Share by Players (2017-2022)
Table 17. Global Top Small Molecule Targeted Cancer Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2021)
Table 18. Ranking of Global Top Small Molecule Targeted Cancer Therapy Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Small Molecule Targeted Cancer Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
Table 22. Date of Enter into Small Molecule Targeted Cancer Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2017-2022)
Table 26. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Small Molecule Targeted Cancer Therapy Revenue Market Share by Type (2023-2028)
Table 28. Global Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Small Molecule Targeted Cancer Therapy Revenue Share by Application (2017-2022)
Table 30. Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Small Molecule Targeted Cancer Therapy Revenue Share by Application (2023-2028)
Table 32. North America Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 62. OncoGenex Pharmaceuticals, Inc. Company Details
Table 63. OncoGenex Pharmaceuticals, Inc. Business Overview
Table 64. OncoGenex Pharmaceuticals, Inc. Small Molecule Targeted Cancer Therapy Product
Table 65. OncoGenex Pharmaceuticals, Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022) & (US$ Million)
Table 66. OncoGenex Pharmaceuticals, Inc. Recent Developments
Table 67. Cytokinetics Inc. Company Details
Table 68. Cytokinetics Inc. Business Overview
Table 69. Cytokinetics Inc. Small Molecule Targeted Cancer Therapy Product
Table 70. Cytokinetics Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022) & (US$ Million)
Table 71. Cytokinetics Inc. Recent Developments
Table 72. Hospira Inc. Company Details
Table 73. Hospira Inc. Business Overview
Table 74. Hospira Inc. Small Molecule Targeted Cancer Therapy Product
Table 75. Hospira Inc. Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022) & (US$ Million)
Table 76. Hospira Inc. Recent Developments
Table 77. GlaxoSmithKline plc Company Details
Table 78. GlaxoSmithKline plc Business Overview
Table 79. GlaxoSmithKline plc Small Molecule Targeted Cancer Therapy Product
Table 80. GlaxoSmithKline plc Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022) & (US$ Million)
Table 81. GlaxoSmithKline plc Recent Developments
Table 82. Boehringer Ingelheim GmbH Company Details
Table 83. Boehringer Ingelheim GmbH Business Overview
Table 84. Boehringer Ingelheim GmbH Small Molecule Targeted Cancer Therapy Product
Table 85. Boehringer Ingelheim GmbH Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022) & (US$ Million)
Table 86. Boehringer Ingelheim GmbH Recent Developments
Table 87. Bayer HealthCare AG Company Details
Table 88. Bayer HealthCare AG Business Overview
Table 89. Bayer HealthCare AG Small Molecule Targeted Cancer Therapy Product
Table 90. Bayer HealthCare AG Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022) & (US$ Million)
Table 91. Bayer HealthCare AG Recent Developments
Table 92. Abbott Laboratories Company Details
Table 93. Abbott Laboratories Business Overview
Table 94. Abbott Laboratories Small Molecule Targeted Cancer Therapy Product
Table 95. Abbott Laboratories Revenue in Small Molecule Targeted Cancer Therapy Business (2017-2022) & (US$ Million)
Table 96. Abbott Laboratories Recent Developments
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Small Molecule Targeted Cancer Therapy Market Share by Type: 2021 VS 2028
Figure 2. Monoclonal Antibodies Features
Figure 3. Small Molecules Features
Figure 4. Small Molecule Drug Conjugates Features
Figure 5. Global Small Molecule Targeted Cancer Therapy Market Share by Application: 2021 VS 2028
Figure 6. Lymphoma Case Studies
Figure 7. Melanoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Prostate Cancer Case Studies
Figure 11. Other Cancers Case Studies
Figure 12. Small Molecule Targeted Cancer Therapy Report Years Considered
Figure 13. Global Small Molecule Targeted Cancer Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Small Molecule Targeted Cancer Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Small Molecule Targeted Cancer Therapy Market Share by Region: 2021 VS 2028
Figure 16. Global Small Molecule Targeted Cancer Therapy Market Share by Players in 2021
Figure 17. Global Top Small Molecule Targeted Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Small Molecule Targeted Cancer Therapy Revenue in 2021
Figure 19. North America Small Molecule Targeted Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2028)
Figure 21. North America Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2028)
Figure 22. North America Small Molecule Targeted Cancer Therapy Market Size Share by Country (2017-2028)
Figure 23. United States Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Small Molecule Targeted Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2028)
Figure 27. Europe Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2028)
Figure 28. Europe Small Molecule Targeted Cancer Therapy Market Size Share by Country (2017-2028)
Figure 29. Germany Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Small Molecule Targeted Cancer Therapy Market Size Share by Region (2017-2028)
Figure 39. China Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of FiguresFigure 45. Latin America Small Molecule Targeted Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Small Molecule Targeted Cancer Therapy Market Size Share by Country (2017-2028)
Figure 49. Mexico Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Small Molecule Targeted Cancer Therapy Market Size Share by Country (2017-2028)
Figure 55. Turkey Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Small Molecule Targeted Cancer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. OncoGenex Pharmaceuticals, Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2017-2022)
Figure 59. Cytokinetics Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2017-2022)
Figure 60. Hospira Inc. Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2017-2022)
Figure 61. GlaxoSmithKline plc Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2017-2022)
Figure 62. Boehringer Ingelheim GmbH Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2017-2022)
Figure 63. Bayer HealthCare AG Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2017-2022)
Figure 64. Abbott Laboratories Revenue Growth Rate in Small Molecule Targeted Cancer Therapy Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed